Bringing Innovative Solutions to Healthcare Practitioners.
NeuroAiD™II awarded Gold accreditation by
independent nonprofit Empowered By Evidence (EBE)
Bringing Innovative Solutions to Healthcare Practitioners
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries Of The Possible.
OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY
NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Shaping the Future of Neurological Care
Latest News
Spinal Cord Injury Day: Advancing Recovery, Care and Quality of Life
Today is Spinal Cord Injury Day!
Join the ASAP Webinar: Exploring Patent Foramen Ovale and Stroke
Spinal Cord Injury Day: Supporting Independence and Quality of Life After SCI
Spinal Cord Injury Day is just around the corner! Globally, over 15 million people are living with spinal cord injury (SCI).
Advancing Neurorehabilitation: Highlights from Moleac’s Regional Scientific Summit in Bali
Stronger Together: Highlights from Moleac’s Annual Company Outing in Ho Chi Minh City
Our annual company outing took us to Ho Chi Minh City, Vietnam!
Predicting Cognitive Decline After Stroke: New Tools for Early Risk Identification
Can a Healthy Diet Delay Dementia? New Evidence in Older Adults With Alzheimer’s Pathology
📰🧠🔬 DEMENTIA STUDY HIGHLIGHTS – Diet Quality and Dementia Risk in Older Adults With Alzheimer Pathology by Mrhar A., et al.
Highlights from Moleac’s AAIC 2026 Symposium on Alzheimer’s Disease
Last night, Moleac hosted a symposium on The Role of NeuroAiD in the Management of Alzheimer’s Disease.
Visit Moleac Today at AAIC 2026 – Booth #1030
Moleac is attending the Alzheimer’s Association International Conference (AAIC) 2026 in London, UK, from July 12–15.
Meet Moleac at AAIC 2026: Advancing Alzheimer’s Disease Care Together
Moleac is attending the Alzheimer’s Association International Conference (AAIC) 2026 in London, UK (July 12–15).
